HANTAAN virus research reveals how regulatory immune cells protect against kidney damage while potentially delaying viral clearance.
New findings highlight a complex relationship between antiviral immunity and tissue injury in hemorrhagic fever with renal syndrome (HFRS), identifying CD8+ regulatory T cells as potential targets for future therapeutic strategies.
Hantaan virus infection can cause HFRS, a potentially severe condition characterized by renal injury and immune dysfunction. Although virus-specific CD8+ T cells contribute to viral elimination, their activity can also trigger damaging inflammatory responses.
Researchers investigated a subset of CD8+ regulatory T cells restricted by the immune recognition molecule HLA-E, examining their characteristics in patients with HFRS and their function in a mouse model of infection.
Blood samples from patients with HFRS revealed significantly reduced levels of these regulatory T cells. The remaining cells exhibited features of terminal differentiation, including increased expression of inhibitory and regulatory markers KLRG-1, NKG2A, CTLA-4, and Fas-L.
These changes correlated with disease severity, suggesting that altered immune regulation may contribute to more severe Hantaan virus infection.
To investigate the mechanisms underlying these findings, researchers identified two Hantaan virus glycoprotein peptides capable of binding Qa-1, the mouse equivalent of HLA-E.
Following peptide immunization and subsequent viral challenge, wild-type mice demonstrated reduced renal immunopathology.
However, genetically modified mice with disrupted Qa-1 interactions showed improved viral clearance in the kidneys and spleen but experienced more severe renal tissue damage.
The findings demonstrate that regulatory immune responses can protect against inflammatory injury while simultaneously restricting the body’s ability to eliminate infection.
Further experiments showed that Qa-1-restricted CD8+ regulatory T cells suppressed the proliferation of antiviral effector T cells through peptide-specific interactions and increased transforming growth factor beta (TGF-β) secretion.
Disrupting these interactions impaired antigen-specific immune suppression, despite compensatory increases in inhibitory markers among the broader regulatory T cell population.
The findings identify the HLA-E/CD8+ regulatory T cell pathway as a potential target for host-directed therapies in HFRS and related viral hemorrhagic fevers.
However, therapeutic strategies would need to balance the benefits of limiting inflammatory kidney damage against the potential consequences of delayed viral clearance. Further investigation is required to determine whether manipulating this pathway can improve clinical outcomes in patients.
Reference
Tang K et al. CD8+ regulatory T cells limit immunopathology but impair viral clearance in Hantaan virus infection. Proc Natl Acad Sci U S A. 2026;123(45):e2536836123.
Featured Image: chokniti on Adobe Stock.
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
